Results 31 to 40 of about 180 (132)

Synthesis of Diaryl‐ and Dialkynylphosphinates From Ubiquitous PV Sources via a Redox‐Neutral Approach

open access: yesAdvanced Science, Volume 12, Issue 36, September 25, 2025.
Classical strategies for P─C bond formation rely on precursors (e.g., PH3, H2PO2, PCl3) obtained from P4, which is produced via the energy‐intensive thermal process. Here, an alternative, redox‐neutral approach is explored. Primary phosphate sources are activated with triflic anhydride (Tf2O) and 4‐dimethylaminopyridine (DMAP) to a versatile PV ...
Tobias Schneider   +5 more
wiley   +1 more source

Evaluating chronopharmacological effectiveness of fosinopril and its combination with melatonin in elderly patients with hypertension and coronary artery disease

open access: yesМедицинский совет, 2014
High incidence of cardiovascular diseases globally, including arterial hypertension (AH) and coronary artery disease (CAD), as well as a considerable social impact made by the diseases and their complications, call for finding new ways to improve ...
O. A. Lednev
doaj   +1 more source

Angiotensinogen II Receptor Blockers May Decrease Risk of Adhesive Capsulitis After Rotator Cuff Repair

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, Volume 7, Issue 4, August 2025.
Purpose To determine the effect of commonly prescribed antifibrotic medications on the odds of developing adhesive capsulitis (AC) following arthroscopic rotator cuff repair. Methods The Mariner data set of the PearlDiver database from 2010 to 2022 was used to identify patients aged 40 to 65 years who underwent rotator cuff repair (identified by ...
Cody S. Lee   +4 more
wiley   +1 more source

The role of fosinopril in the treatment and prevention of cardiovascular diseases

open access: yesМедицинский совет, 2015
In Russia, cardiovascular diseases account for 57% of deaths in the overall mortality. Arterial hypertension (AH) is one of the main risk factors (RF) for cardiovascular diseases (along with dyslipidemia, smoking, metabolic syndrome, diabetes mellitus ...
G. A. Baryshnikova
doaj   +1 more source

Efficacy and safety of traditional Chinese medicine and SGLT2i, GLP‐1RA, and ACEI/ARB in the management of diabetic kidney disease: A systematic review and network meta‐analysis

open access: yesRheumatology &Autoimmunity, Volume 5, Issue 1, Page 37-49, March 2025.
A network meta‐analysis was carried out to identify the most recommended therapeutic schedule for patients with diabetic kidney disease. The study finally included 87 randomized‐controlled trials, including 16 different treatments and 10,485 patients.
Jiarong Liu, Jixiong Xu
wiley   +1 more source

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome

open access: yesРоссийский кардиологический журнал, 2006
The aim of the study was to assess therapeutic effects offosinopril on intravascular platelet (PL) activity inpatients with arterial hypertension (AH) and metabolic syndrome (MS). Thirty-three patients received fosinopril (10 mg/d) for 4 months. Dynamics
I. N. Medvedev, V. V. Tolmachev
doaj  

Effect of protease inhibitors on the intraerythrocytic development of Babesia microti and Babesia duncani, the causative agents of human babesiosis

open access: yesJournal of Eukaryotic Microbiology, Volume 72, Issue 2, March/April 2025.
Abstract Human babesiosis is a malaria‐like, tick‐borne infectious disease with a global distribution. Babesiosis is caused by intraerythrocytic, apicomplexan parasites of the genus Babesia. In the United States, human babesiosis is caused by Babesia microti and Babesia duncani.
Temitope Aderanti   +2 more
wiley   +1 more source

Drug‐Induced Liver Injury in Patients With Chronic Liver Disease

open access: yesLiver International, Volume 45, Issue 3, March 2025.
ABSTRACT Objective Drug‐induced liver injury (DILI) is a global problem and can develop from exposure to prescription or over‐the‐counter medications as well as herbal and dietary supplements. The diagnosis of DILI is clinically challenging, and liver injury can be severe leading to liver failure, death, or liver transplantation.
Marwan Ghabril   +2 more
wiley   +1 more source

Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2006
INTRODUCTION The cardiovascular changes (vascular structure changes, hypertrophy of the left ventricle) contribute to both the increased cardiovascular morbidity and the mortality of essential hypertension.
Tasić Ivan   +6 more
doaj   +1 more source

Genetic polymorphisms influencing antihypertensive drug responses

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 4, Page 929-950, February 2025.
Abstract Hypertension is a major contributor to cardiovascular disease and its associated morbidity and mortality. The low efficacy observed with some anti‐hypertensive therapies has been attributed partly to inter‐individual genetic variability. This paper reviews the major findings regarding these genetic variabilities that modulate responses to anti‐
Jana El Cheikh   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy